Abbott Acquires Cardiovascular Systems, Inc.

February 8, 2023

Abbott has agreed to acquire Cardiovascular Systems, Inc. (CSI) for $20.00 per share, representing an expected equity value of approximately $890 million. The acquisition adds CSI's orbital atherectomy system and early-stage vascular intervention pipeline to Abbott's vascular device portfolio to expand its capabilities in treating peripheral and coronary artery disease.

Buyers
Abbott
Targets
Cardiovascular Systems, Inc.
Sellers
Cardiovascular Systems, Inc. stockholders
Industry
Medical Devices
Location
Minnesota, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.